Adding daratumumab to lenalidomide maintenance therapy after transplant in patients with multiple myeloma triples the minimal residual disease (MRD)–negative conversion rate to 50.5% vs 18.8% with ...
NEW YORK, Dec 17 (Reuters) - Weyerhaeuser Co's decision to convert into a real estate investment trust is likely to be negative for the company's credit profile, though this weakness may have already ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results